CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,305 | -39.8% | 14,957 | 0.0% | 0.00% | – |
| Q2 2023 | $8,811 | +3.3% | 14,957 | 0.0% | 0.00% | – |
| Q1 2023 | $8,533 | -14.5% | 14,957 | 0.0% | 0.00% | – |
| Q4 2022 | $9,976 | -60.1% | 14,957 | -11.8% | 0.00% | – |
| Q3 2022 | $25,000 | +56.2% | 16,957 | +13.4% | 0.00% | – |
| Q2 2022 | $16,000 | -65.2% | 14,957 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | -20.7% | 14,957 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | -26.6% | 14,957 | 0.0% | 0.00% | – |
| Q3 2021 | $79,000 | -11.2% | 14,957 | 0.0% | 0.00% | – |
| Q2 2021 | $89,000 | – | 14,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,000 | $1,778,000 | 0.97% |
| Affinity Asset Advisors, LLC | 380,000 | $2,702,000 | 0.92% |
| Tri Locum Partners LP | 293,419 | $2,086,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $3,614,000 | 0.28% |
| J. Goldman & Co LP | 357,524 | $2,542,000 | 0.08% |
| Maven Securities LTD | 250,000 | $1,787,000 | 0.08% |
| Ikarian Capital, LLC | 300,000 | $2,133,000 | 0.07% |
| PURA VIDA INVESTMENTS, LLC | 273,958 | $1,948,000 | 0.06% |
| CVI Holdings, LLC | 59,450 | $423,000 | 0.03% |
| Schonfeld Strategic Advisors LLC | 136,725 | $972,000 | 0.01% |